Workflow
Biofermentation
icon
Search documents
Kerry Group Conference: Biotech Push, Volume-Led Growth, and 19–20% EBITDA Margin Target by 2028
Yahoo Finance· 2026-02-19 14:36
Scanlon argued that biotechnology and biofermentation are increasingly central to solving industry challenges, citing pressures such as climate volatility, finite raw materials, and consumer demands for simpler labels, better nutrition, functional benefits, and authentic taste at a competitive cost. He said biotechnology enables scalable solutions that are not limited by traditional agriculture and can support cleaner labels, improved nutrition, consistent taste, and reduced environmental impact.Scanlon hig ...